Group 1 - The core finding of the research indicates that obesity impairs gut repair through elevated levels of adipocyte fatty acid-binding protein (AFABP), which leads to iron overload in intestinal stem cells (ISCs) [2][6] - The study identifies the adipose tissue-gut signaling axis as a new therapeutic target for obesity-related intestinal diseases [3][7] - Increased AFABP secretion in obesity disrupts iron homeostasis in ISCs, hindering their differentiation, which is crucial for gut repair after injury [6] Group 2 - Overexpression of AFABP in adipocytes of lean mice obstructs ISC differentiation and gut repair, while reducing AFABP levels or using AFABP inhibitors, iron chelators, or peroxisome proliferator-activated receptor (PPAR) agonists can alleviate colitis in obese mice [6]

Core Viewpoint - The research highlights the role of the fungal commensal Kazachstania pintolopesii (Kp) in promoting intestinal repair through its secreted peptide, CD12, marking a significant advancement in understanding gut regeneration mechanisms and positioning gut fungi as potential biotherapeutics for inflammatory and iatrogenic bowel diseases [3][7]. Group 1 - The study confirms that the secreted protein Ygp1 from Kp plays a crucial mediating role in intestinal regeneration [6]. - A 12-amino acid peptide fragment, CD12, derived from Ygp1, is sufficient to promote differentiation of intestinal organoids and accelerate gut healing in mouse models of colitis and chemotherapy-induced damage [6]. - CD12 interacts with mammalian α-enolase (ENO1), increasing YAP1 protein levels and activating regeneration-related transcriptional programs via the Hippo signaling pathway [6]. Group 2 - The research provides a translatable delivery strategy by demonstrating that engineered probiotics expressing CD12 can replicate its therapeutic benefits [6].